List of insiders holdings for TransMedics Group Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Flagship Ventures Fund IV General Partner LLC Flagship Ventures Fund IV L.P. Flagship Ventures 2007 General Partner LLC Flagship Ventures Fund 2007 L.P. AFEYAN NOUBAR 10% Owner | 2019-10-31 19:00:29 | 0 2,960,786 | 2,960,786 | Form 4 |
| ABRAMS CAPITAL MANAGEMENT L.P. ABRAMS CAPITAL MANAGEMENT LLC Abrams Capital Partners II L.P. ABRAMS CAPITAL LLC Abrams David C Riva Capital Partners III L.P. Riva Capital Management III LLC 10% Owner | 2021-02-16 16:01:08 | 1,302,612 0 | 1,302,612 | Form 13G |
| Hassanein Waleed H President & CEO | 2024-10-17 16:30:04 | 157,893 469,359 | 627,252 | Form 4 |
| KANIA EDWIN M JR Director | 2024-05-28 17:30:16 | 259,830 46,142 | 305,972 | Form 4 |
| Godhani Rakesh P. Chief Digital Officer | 2021-08-06 17:05:31 | 140,000 0 | 140,000 | Form 4 |
| Corcoran Nicholas See Remarks | 2024-08-29 16:30:11 | 48,469 0 | 48,469 | Form 4 |
| Provost Miriam VP, Global Regulatory Affairs | 2023-12-15 17:31:17 | 46,045 0 | 46,045 | Form 4 |
| Gordon Stephen Chief Financial Officer | 2024-06-05 17:12:25 | 36,716 0 | 36,716 | Form 4 |
| Carey John F VP of Operations | 2023-02-03 17:12:57 | 32,550 0 | 32,550 | Form 4 |
| Sullivan John F VP of Quality & Engineering | 2021-09-01 17:04:44 | 30,045 0 | 30,045 | Form 4 |
| Khayal Tamer I Chief Commercial Officer | 2024-11-13 16:30:15 | 26,677 0 | 26,677 | Form 4 |
| TOBIN JAMES R Director | 2024-09-17 19:27:27 | 1,925 18,000 | 19,925 | Form 4 |
| Ranganath Anil P. See remarks | 2024-08-09 16:30:19 | 19,313 0 | 19,313 | Form 4 |
| DAMME LAURA VP, Clinical Affairs | 2023-02-22 20:00:40 | 14,390 0 | 14,390 | Form 4 |
| Weill David Director | 2024-05-31 16:30:07 | 10,732 0 | 10,732 | Form 4 |
| RAINES MERILEE Director | 2024-05-28 17:30:17 | 3,079 0 | 3,079 | Form 4 |
| Gunderson Thomas James Director | 2024-05-28 17:30:41 | 3,079 0 | 3,079 | Form 4 |
| Lovell Stephanie Director | 2024-05-28 17:30:11 | 3,079 0 | 3,079 | Form 4 |
| Basile Edward M Director | 2024-11-07 16:30:11 | 732 0 | 732 | Form 4 |
| Gilbert James Director | 2019-05-01 19:06:22 | 0 0 | 0 | Form 3 |
| UNITED THERAPEUTICS Corp Lung Biotechnology PBC 10% Owner | 2021-02-05 06:04:18 | 0 0 | 0 | Form 13G |